Atlas Trials

Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer

Clinical trial NCT00583024 · COMPLETED

Trial details

NCT number
NCT00583024
Sponsor
David M Lubaroff
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hormone Refractory Prostate Cancer
Start date
2007-12-01
Primary completion
2020-12-31
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.